Stony Brook University Hospital & Medical Center
Cancer Trials
Melanoma
Unresctable Metastatic Malignant Melanoma - Phase III Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma (Luipold Pharm.)
Contact Us
Information supplied by Pat Hentschel
Return to Cancer Clinical Trials
University Hospital and Medical Center
Constructed on December 22, 1997Barbara Cole of Medical Informatics